Final Glance: Pharmaceuticals companies
AP - Wed Aug 13, 5:15PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Advisory Committee on Immunization Practices Votes to Recommend Pfizer's Prevnar 13(R) Vaccine in Adults Aged 65 Years and Older
Business Wire - Wed Aug 13, 4:43PM CDT
Pfizer Inc. (NYSE
Midday Glance: Pharmaceuticals companies
AP - Wed Aug 13, 12:50PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Pfizer (PFE) Approaches New Upside Target of $28.49
Comtex SmarTrend(R) - Wed Aug 13, 10:43AM CDT
Pfizer (NYSE
Early Glance: Pharmaceuticals companies
AP - Wed Aug 13, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
RiverVest Venture Partners' Otonomy Completes $100 Million Initial Public Offering
Business Wire - Wed Aug 13, 9:23AM CDT
Otonomy, a RiverVest Fund II portfolio company that develops drug therapies for the inner and middle ear, announced today its $100 million initial public offering.
Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:10AM CDT
Athersys, Inc. announced second quarter 2014 net loss of 9 cents (adjusting one-time items) per share.
Most active New York Stock Exchange-traded stocks
AP - Tue Aug 12, 5:11PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Business Highlights
By The Associated Press - AP - Tue Aug 12, 5:05PM CDT
___
UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 4:05PM CDT
As per Bloomberg, the Swiss major UBS AG (UBS) is planning corporate bond offerings in the U.S. The bank will be issuing $4.5 billion worth of bonds.
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy Lyrica(R) Studies Conducted in China
Business Wire - Tue Aug 12, 4:02PM CDT
Pfizer Inc. (NYSE
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PR Newswire Europe - Tue Aug 12, 12:50PM CDT
DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets [http://www.researchandmarkets.com/research/kpr76z/biological_drugs] has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" [http://www.researchandmarkets.com/research/kpr76z/biological_drugs] report to their offering.
5 Things Pfizer Inc.'s Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Tue Aug 12, 12:27PM CDT
Big pharma giant Pfizer reported its second quarter earnings results two weeks ago, reminding shareholders that the patent cliff is very real, and that its operations are going through a sizable shift. For the quarter, Pfizer reported that...
Pfizer, 23andMe team up to study bowel disease
By MATTHEW PERRONE - AP - Tue Aug 12, 10:24AM CDT
WASHINGTON (AP) — Pfizer Inc. is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.
Study Links Viagra(R) to Skin Cancer
Marketwire - Tue Aug 12, 10:20AM CDT
A recent study published in The Journal of the American Medical Association found that men who take Viagra® have an almost 84 percent greater risk of developing melanoma, one of the most aggressive forms of skin cancer. The study analyzed data from more than 25,000 men and controlled for factors such as sun exposure and family medical history.
Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics
PR Newswire - Tue Aug 12, 8:00AM CDT
On Monday, August 11, 2014, the NASDAQ Composite ended at 4,401.33, up 0.70%, the Dow Jones Industrial Average advanced 0.10%, to finish the day at 16,569.98, and the S&P 500 closed at 1,936.92, up 0.28%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 700.04, up 0.01%, with the index also advancing 4.74 % in the previous three months. Investor-Edge has initiated coverage on the following equities: Pfizer Inc. (NYSE: PFE), BioDelivery Sciences International Inc. (NASDAQ: BDSI), The Medicines Company (NASDAQ: MDCO), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), and Nektar Therapeutics (NASDAQ: NKTR). Free research on these five companies can be accessed at: